EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Effectiveness and Tolerability of Topical Amitriptyline 10% Plus Lidocaine 2% Gel in Adults With Post‐Traumatic Trigeminal Neuropathic Pain: A Real‐World Evidence Study

Ashley Lebel iD, Imen Stambouli, Yves Boucher iD

Journal of Oral Rehabilitation · 2026

DOI: 10.1111/joor.70209 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Oral Rehabilitation, 2026. Verfasst von Ashley Lebel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orofacial Pain, Institute of Dental Surgery, Pitié-Salpêtrière Hospital (AP-HP), Paris, France. Hauptthemen laut MEDLINE: Amitriptyline, Analgesics, Non-Narcotic, Lidocaine, Anesthetics, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post‐traumatic trigeminal neuropathic pain (PTNP) is a debilitating orofacial pain disorder most commonly caused by trigeminal nerve injury after dental procedures or facial trauma. Available systemic therapies have modest and inconsistent efficacy, with substantial tolerability concerns limiting adherence.

Objectives

To evaluate the real‐world effectiveness and tolerability of a compounded intraoral mucoadhesive gel containing amitriptyline 10% plus lidocaine 2% in adults with PTNP.

Methods

This retrospective real‐world evidence study included adults with PTNP meeting ICHD ‐3/ ICOP criteria who were treated at a tertiary orofacial pain clinic from May 1, 2023, to April 30, 2024. The primary outcome was the within‐patient change in pain intensity on a 0–10 numerical rating scale ( NRS ) from baseline to week 8. Secondary outcomes included responder rates (≥ 50% and ≥ 30% pain reduction), patient global impression of improvement ( PGI ‐I) and adverse events ( AEs ).

Results

Of 94 patients identified, 40 were included in the complete‐case initiator cohort. Mean pain intensity decreased from 6.3 ± 1.7 at baseline to 3.0 ± 2.7 at week 8, corresponding to a mean within‐patient reduction of 3.30 points (95% CI, 2.51–4.09; p < 0.001). Twenty‐two of 40 patients (55%; 95% CI, 40–69) achieved a ≥ 50% reduction in pain intensity, and 27 of 40 (68%; 95% CI, 52–80) achieved a ≥ 30% pain reduction. Seventy‐five percent (30/40, 95% CI, 60–86) reported overall improvement on the PGI ‐I. Mild treatment‐related AEs occurred in five of 40 patients (12%); no serious AEs or treatment discontinuations were reported.

Conclusion

In this retrospective real‐world study, topical amitriptyline–lidocaine mucoadhesive gel was associated with statistically significant and clinically meaningful pain improvement in adults with PTNP , together with favourable tolerability. These findings support targeted mucosal delivery as a promising local therapeutic option and potential medication‐sparing strategy, particularly when systemic therapies are ineffective or poorly tolerated. Randomized controlled trials are now needed to confirm efficacy and clarify the role of topical amitriptyline in PTNP treatment pathways and routine clinical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmitriptylineAnalgesics, Non-NarcoticLidocaineAnesthetics, LocalTrigeminal Nerve DiseasesGelsAdministration, TopicalDrug Therapy, CombinationPain ManagementPain MeasurementTreatment OutcomeRetrospective StudiesHumansMaleFemaleAdultMiddle AgedAged

Stichwörter der Autor:innen

dental implantsendodonticspainful post‐traumatic trigeminal neuropathytooth extractiontopical analgesictrigeminal nerve injuriestrigeminal neuralgia

Substanzen

AmitriptylineAnalgesics, Non-NarcoticLidocaineAnesthetics, LocalGels

Autor:innen und Institutionen

  • Department of Orofacial Pain, Institute of Dental Surgery, Pitié-Salpêtrière Hospital (AP-HP), Paris, France.
  • Laboratory of Orofacial Neurobiology, Inserm UMR1333 Oral Heath, Université Paris Cité, Montrouge, France.
  • Gene Regulation and Adaptive Behaviors, Center for Neuroscience Sorbonne University (NeuroSU), Sorbone Université, Paris, France.
  • Unit of Orofacial Pain and Temporomandibular Dysfunction, University Dental Clinic, Monastir, Tunisia.

ORCID-Profile: Ashley Lebel, Yves Boucher

Zitieren

APA

Lebel, A., Stambouli, I., & Boucher, Y. (2026). Effectiveness and Tolerability of Topical Amitriptyline 10% Plus Lidocaine 2% Gel in Adults With Post‐Traumatic Trigeminal Neuropathic Pain: A Real‐World Evidence Study. Journal of Oral Rehabilitation. https://doi.org/10.1111/joor.70209

Vancouver

Lebel A, Stambouli I, Boucher Y. Effectiveness and Tolerability of Topical Amitriptyline 10% Plus Lidocaine 2% Gel in Adults With Post‐Traumatic Trigeminal Neuropathic Pain: A Real‐World Evidence Study. Journal of Oral Rehabilitation. 2026. doi:10.1111/joor.70209

BibTeX
@article{Lebel2026,
  author = {Lebel, Ashley and Stambouli, Imen and Boucher, Yves},
  title = {Effectiveness and Tolerability of Topical Amitriptyline 10% Plus Lidocaine 2% Gel in Adults With Post‐Traumatic Trigeminal Neuropathic Pain: A Real‐World Evidence Study},
  journal = {Journal of Oral Rehabilitation},
  year = {2026},
  doi = {10.1111/joor.70209}
}
Kostenlos starten →